With heightened regulatory scrutiny and intense price fluctuations, some analysts are bearish on bitcoin’s prospects.Read More
You might also be interested in reading IDEXX, DexCom lead S&P 500 healthcare gains in Q2; UnitedHealth and Bristol Myers Squibb among top laggards.